Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT07370207 |
| Consolidated Lead Sponsor | AusperBio Therapeutics |
| Therapeutic Condition Cohort | Infectious Disease and Vaccines |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 84 participants (ESTIMATED) |
| Registered Start Date | 2026-03-06 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Asan Medical Center | Seoul, South Korea | Open Hospital Dossier -> |
| National Taiwan University Hospital | Taipei, Taiwan | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Infectious Disease and Vaccines Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.